Key result
Renal sympathetic denervation requires further investigation and reassessment for treating resistant hypertension in the aftermath of the Symplicity HTN-3 trial.
Key points are not available for this paper at this time.
Supports restricting renal denervation to trials in resistant hypertension; reinforces post-Symplicity HTN-3 reevaluation.
status: Published
No takes yet. Share an insight, caveat, or question.
Kjeldsen et al. (2014) studied this question. Renal sympathetic denervation requires further investigation and reassessment for treating resistant hypertension in the aftermath of the Symplicity HTN-3 trial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: